https://www.zacks.com/stock/news/2208275/are-medical-stocks-lagging-cigna-group-ci-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2208275
Jan 10, 2024 - Here is how Cigna (CI) and Akoya Biosciences (AKYA) have performed compared to their sector so far this year.
zc:-261586156201580565
0
https://www.zacks.com/stock/news/2208976/can-unitedhealth-s-unh-unitedhealthcare-unit-aid-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2208976
Jan 11, 2024 - UnitedHealth's (UNH) fourth-quarter results are expected to benefit from an increase in UnitedHealthcare's Medicare & Retirement revenues as well as the number of people it served.
zc:-1125406175945343028
0
https://www.zacks.com/stock/news/2220249/compared-to-estimates-cigna-ci-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2220249
Feb 02, 2024 - While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-6136342845322493243
0
https://www.zacks.com/commentary/2220988/top-analyst-reports-for-meta-platforms-eaton-cigna?cid=CS-ZC-FT-research_daily-2220988
Feb 05, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Eaton Corporation plc (ETN) and The Cigna Group (CI).
zc:-9183968651375272413
0
https://www.zacks.com/stock/news/2222024/centene-cnc-q4-earnings-beat-on-membership-growth-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2222024
Feb 06, 2024 - Centene (CNC) expects adjusted EPS to be a minimum of $6.70 in 2024, higher than the 2023 figure of $6.68 per share.
zc:-2501692719850028359
0
https://www.zacks.com/stock/news/2223634/molina-healthcare-moh-q4-earnings-beat-on-premium-growth?cid=CS-ZC-FT-analyst_blog|earnings_article-2223634
Feb 08, 2024 - Molina Healthcare (MOH) expects adjusted EPS to be at a minimum of $23.5 in 2024, which represents a year-over-year improvement of 12.5%.
zc:-9213798771273917717
0
https://www.zacks.com/stock/news/2228719/cigna-ci-upgraded-to-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2228719
Feb 20, 2024 - Cigna (CI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zc:-5841843127449506663
0
https://www.zacks.com/stock/news/2233930/why-cigna-ci-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2233930
Feb 29, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zc:-3977503513983822168
0
https://www.zacks.com/stock/news/2234855/centene-cnc-pyx-health-unite-to-treat-mental-health-issues?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2234855
Mar 01, 2024 - Centene (CNC) partners with Pyx Health to address loneliness and mental health issues among the insured.
zc:-848203501235206719
0
https://www.zacks.com/commentary/2236265/3-top-ranked-stocks-to-buy-for-stability?cid=CS-ZC-FT-investment_ideas-2236265
Mar 05, 2024 - Targeting low-beta stocks can provide a valuable layer of stability for portfolios. After all, defense wins ballgames.
zc:251403302678507286
0